Literature DB >> 11992582

Incidence and case-fatality rates resulting from the 1998 enterovirus 71 outbreak in Taiwan.

Chun-Yi Lu1, Chin-Yun Lee, Chuan-Liang Kao, Wen-Yi Shao, Ping-Ing Lee, Shiing-Jer Twu, Chin-Chuan Yeh, Shang-Ching Lin, Wen-Yi Shih, Shiow-Ing Wu, Li-Min Huang.   

Abstract

In 1998, an epidemic of hand-foot-and-mouth disease and herpangina caused by enterovirus 71 occurred in Taiwan, leaving many fatalities and severely handicapped survivors in its wake. The reasons this rather common pathogen would cause such a large-scale epidemic remain unknown. A seroepidemiological survey to elucidate the epidemiological characteristics of this outbreak, including its incidence and case-fatality rates was undertaken. Microneutralization tests for antibodies against enterovirus 71 were used to screen four collections of serum samples: 1) 202 specimens taken from individuals > or = 4 years old in 1994; 2) 245 specimens collected from individuals of all ages in 1997; 3) 1,258 specimens collected from individuals of all ages in 1999; and 4) sera samples from a birth cohort of 81 children who had yearly blood samples taken from 1988-98. After the maternal antibody had declined, the seropositive rates began to increase with age. Approximately half of all children aged 6 years or older were enterovirus 71 seropositive. Significantly higher seropositive rates were noted in 1999 than in 1997, in children aged 0.5-3 years. The incidence of enterovirus 71 infection during the epidemic was estimated to be 13-22%, with the higher rates in younger children. The case-fatality rate was highest (96.96 per 100,000) in infants aged 6-11 months, and declined in older children. The results showed that enterovirus 71 is endemic in Taiwan. The apparent lack of large-scale enterovirus 71 activity in the 3 years before 1998 might have been the prelude to the epidemic's appearance in 1998, and might suggest that enterovirus 71 infection will reappear every few years. The lack of a protective antibody in younger children may account for the high incidence and case-fatality rate in this age group. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11992582     DOI: 10.1002/jmv.2210

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  31 in total

1.  Reemerging of enterovirus 71 in Taiwan: the age impact on disease severity.

Authors:  S-M Wang; T-S Ho; H-C Lin; H-Y Lei; J-R Wang; C-C Liu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-09       Impact factor: 3.267

2.  Clinical and etiological characteristics of enterovirus 71-related diseases during a recent 2-year period in Korea.

Authors:  Wi-Sun Ryu; Byounghak Kang; Jiyoung Hong; Seoyeon Hwang; Jonghyun Kim; Doo-Sung Cheon
Journal:  J Clin Microbiol       Date:  2010-05-12       Impact factor: 5.948

3.  Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene.

Authors:  Kok Keng Tee; Tommy Tsan-Yuk Lam; Yoke Fun Chan; Jon M Bible; Adeeba Kamarulzaman; C Y William Tong; Yutaka Takebe; Oliver G Pybus
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

Review 4.  Seroprevalence of Enterovirus 71 Antibody Among Children in China: A Systematic Review and Meta-analysis.

Authors:  Bingyi Yang; Peng Wu; Joseph T Wu; Eric H Y Lau; Gabriel M Leung; Hongjie Yu; Benjamin J Cowling
Journal:  Pediatr Infect Dis J       Date:  2015-12       Impact factor: 2.129

5.  An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys.

Authors:  Minetaro Arita; Noriyo Nagata; Naoko Iwata; Yasushi Ami; Yuriko Suzaki; Katsumi Mizuta; Takuya Iwasaki; Tetsutaro Sata; Takaji Wakita; Hiroyuki Shimizu
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

Review 6.  Enteroviruses in the early 21st century: new manifestations and challenges.

Authors:  Debra Lugo; Paul Krogstad
Journal:  Curr Opin Pediatr       Date:  2016-02       Impact factor: 2.856

7.  Enterovirus 71 maternal antibodies in infants, Taiwan.

Authors:  Shu Ting Luo; Pai Shan Chiang; An Shine Chao; Guan Yuan Liou; Reyin Lin; Tzou Yien Lin; Min Shi Lee
Journal:  Emerg Infect Dis       Date:  2009-04       Impact factor: 6.883

Review 8.  Challenges to licensure of enterovirus 71 vaccines.

Authors:  Min-Shi Lee; Fan-Chen Tseng; Jen-Ren Wang; Chia-Yu Chi; Pele Chong; Ih-Jen Su
Journal:  PLoS Negl Trop Dis       Date:  2012-08-28

9.  Seroepidemiology of human enterovirus71 and coxsackievirusA16 in Jiangsu province, China.

Authors:  Hong Ji; Liang Li; YanMing Liu; HengMing Ge; XuShan Wang; Jianli Hu; Bin Wu; JianGuang Fu; ZhenYu Zhang; XiaoQin Chen; MingLei Zhang; Qiang Ding; WenBo Xu; FenYang Tang; MingHao Zhou; Hua Wang; FengCai Zhu
Journal:  Virol J       Date:  2012-10-29       Impact factor: 4.099

Review 10.  Strategies to develop antivirals against enterovirus 71.

Authors:  Rei-Lin Kuo; Shin-Ru Shih
Journal:  Virol J       Date:  2013-01-22       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.